BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19760374)

  • 1. Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.
    Bausch D; Mino-Kenudson M; Fernández-Del Castillo C; Warshaw AL; Kelly KA; Thayer SP
    J Gastrointest Surg; 2009 Nov; 13(11):1948-54; discussion 1954. PubMed ID: 19760374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
    Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
    Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
    Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
    Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.
    Moris M; Dawson DW; Jiang J; Lewis J; Nassar A; Takeuchi KK; Lay AR; Zhai Q; Donahue TR; Kelly KA; Crawford HC; Wallace M
    Pancreas; 2016 Oct; 45(9):1353-8. PubMed ID: 27101571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
    Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
    Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].
    Distler M; Welsch T; Aust D; Weitz J; Grützmann R
    Zentralbl Chir; 2014 Jun; 139(3):308-17. PubMed ID: 24241954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
    BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
    Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
    Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
    Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
    Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synchronous malignant intraductal papillary mucinous neoplasms of the bile duct and pancreas requiring left hepatectomy and total pancreatectomy].
    Moon DB; Lee SG; Jung DH; Park GC; Park YH; Park HW; Kim MH; Lee SK; Yu ES; Kim JH
    Korean J Gastroenterol; 2014 Feb; 63(2):129-33. PubMed ID: 24561701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
    Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
    Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas.
    Tanaka M
    Dig Endosc; 2015 May; 27(4):450-457. PubMed ID: 25588761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
    Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
    Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of mixed adenoneuroendocrine carcinoma of the pancreas mimicking intraductal papillary mucinous carcinoma.
    Mori H; Hanada K; Minami T; Yano S; Fukuhara M; Maruyama H; Shimizu A; Hirano N; Hino F; Amano H; Yonehara S
    Clin J Gastroenterol; 2018 Aug; 11(4):320-326. PubMed ID: 29442219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
    Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
    JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Static and Dynamic
    Lang M; Spektor AM; Hielscher T; Hoppner J; Glatting FM; Bicu F; Hackert T; Heger U; Pausch T; Gutjahr E; Rathke H; Giesel FL; Kratochwil C; Tjaden C; Haberkorn U; Röhrich M
    J Nucl Med; 2023 Feb; 64(2):244-251. PubMed ID: 35906094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E
    Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
    J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.